Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 440

Similar articles for PubMed (Select 19446661)

1.

Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients.

Gaafar A, Aljurf MD, Al-Sulaiman A, Iqniebi A, Manogaran PS, Mohamed GE, Al-Sayed A, Alzahrani H, Alsharif F, Mohareb F, Ajarim D, Tabakhi A, Al-Hussein K.

Exp Hematol. 2009 Jul;37(7):838-48. doi: 10.1016/j.exphem.2009.04.003. Epub 2009 May 14.

PMID:
19446661
2.

Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.

Kondo M, Sakuta K, Noguchi A, Ariyoshi N, Sato K, Sato S, Sato K, Hosoi A, Nakajima J, Yoshida Y, Shiraishi K, Nakagawa K, Kakimi K.

Cytotherapy. 2008;10(8):842-56. doi: 10.1080/14653240802419328.

PMID:
19016372
3.

Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2.

Li W, Kubo S, Okuda A, Yamamoto H, Ueda H, Tanaka T, Nakamura H, Yamanishi H, Terada N, Okamura H.

J Immunother. 2010 Apr;33(3):287-96. doi: 10.1097/CJI.0b013e3181c80ffa.

PMID:
20445349
4.

Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.

Watanabe N, Narita M, Yokoyama A, Sekiguchi A, Saito A, Tochiki N, Furukawa T, Toba K, Aizawa Y, Takahashi M.

Cytotherapy. 2006;8(2):118-29.

PMID:
16698685
5.

Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy?

Aswald JM, Wang XH, Aswald S, Lutynski A, Minden MD, Messner HA, Keating A.

Cytometry B Clin Cytom. 2006 Nov 15;70(6):379-90.

6.

Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.

Guo BL, Liu Z, Aldrich WA, Lopez RD.

Breast Cancer Res Treat. 2005 Sep;93(2):169-75.

PMID:
16187237
7.
8.

Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation.

Otto M, Barfield RC, Iyengar R, Gatewood J, Müller I, Holladay MS, Houston J, Leung W, Handgretinger R.

J Immunother. 2005 Jan-Feb;28(1):73-8.

PMID:
15614047
9.

Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood.

Kang N, Zhou J, Zhang T, Wang L, Lu F, Cui Y, Cui L, He W.

Cancer Biol Ther. 2009 Aug;8(16):1540-9. Epub 2009 Aug 8.

10.
11.

Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.

Wong PY, Staren ED, Tereshkova N, Braun DP.

J Surg Res. 1998 Apr;76(1):95-103.

PMID:
9695747
12.

Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma.

Kudoh S, Redovan C, Rayman P, Edinger M, Tubbs RR, Novick A, Finke JH, Bukowski RM.

J Immunother. 1997 Nov;20(6):479-87.

PMID:
9409454
13.

[Amplification of γδ T cells in PBMCs of healthy donors and osteosarcoma patients stimulated by zoledronate].

Li ZX, Sun LL, Cheng RL, Sun ZW, Ye ZM.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Aug;28(8):822-4. Chinese.

PMID:
22863589
14.

Osteosarcoma cell line growth inhibition by zoledronate-stimulated effector cells.

Muraro M, Mereuta OM, Carraro F, Madon E, Fagioli F.

Cell Immunol. 2007 Oct;249(2):63-72. doi: 10.1016/j.cellimm.2007.11.005. Epub 2007 Dec 27.

PMID:
18163982
15.

In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients.

Santini D, Martini F, Fratto ME, Galluzzo S, Vincenzi B, Agrati C, Turchi F, Piacentini P, Rocci L, Manavalan JS, Tonini G, Poccia F.

Cancer Immunol Immunother. 2009 Jan;58(1):31-8. doi: 10.1007/s00262-008-0521-6. Epub 2008 May 6.

PMID:
18458903
16.

Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells.

Shojaei H, Oberg HH, Juricke M, Marischen L, Kunz M, Mundhenke C, Gieseler F, Kabelitz D, Wesch D.

Cancer Res. 2009 Nov 15;69(22):8710-7. doi: 10.1158/0008-5472.CAN-09-1602. Epub 2009 Nov 3.

17.
18.

Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.

Iwasaki M, Tanaka Y, Kobayashi H, Murata-Hirai K, Miyabe H, Sugie T, Toi M, Minato N.

Eur J Immunol. 2011 Feb;41(2):345-55. doi: 10.1002/eji.201040959. Epub 2011 Jan 11.

PMID:
21268005
19.

Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.

Nagamine I, Yamaguchi Y, Ohara M, Ikeda T, Okada M.

Hiroshima J Med Sci. 2009 Mar;58(1):37-44.

PMID:
19400555
20.

Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.

Correia DV, d'Orey F, Cardoso BA, Lança T, Grosso AR, deBarros A, Martins LR, Barata JT, Silva-Santos B.

PLoS One. 2009 May 21;4(5):e5657. doi: 10.1371/journal.pone.0005657.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk